mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work."
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.
.